Status:
COMPLETED
Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study
Lead Sponsor:
University of Cagliari
Conditions:
SARS-CoV Infection
Seroprevalence
Eligibility:
All Genders
18+ years
Brief Summary
The investigator analyzed the data of the patients admitted to the surgical department during the period 1St September - 10Th December 2020 to estimate the seroprevalence of SARS-CoV-2 infection in th...
Eligibility Criteria
Inclusion
- Patient admitted to our unit who had performed SARS-COV-2 serologic test
Exclusion
- age \< 18
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 10 2021
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT04839913
Start Date
September 1 2020
End Date
January 10 2021
Last Update
April 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cagliari
Cagliari, Italy